![NETEC Resource Library](https://repository.netecweb.org/files/theme_uploads/400508e2d5d16a4cdb990b4486af9b3f.png)
Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (107 total)
-
Créateur: Agostini, Maria, Erica Andres, Amy Sims, Rachel Graham, Timothy Sheahan, Xiaotao Lu, Everett Smith, James Case, Joy Feng, Robert Jordan, Adrian Ray, Tomas Cihlar, Dustin Siegel, Richard Mackman, Michael Clarke, Ralph Baric, and Mark Denison.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2018-03
Description: Emerging coronaviruses (CoVs) cause severe disease in humans, but no approved therapeutics are available. -
Créateur: Dean, Natalie E., Pierre-Stéphane Gsell, Ron Brookmeyer, Forrest W. Crawford, Christl A. Donnelly, Susan S. Ellenberg, Thomas R. Fleming, M. Elizabeth Halloran, Peter Horby, Thomas Jaki, Philip R. Krause, Ira M. Longini, Sabue Mulangu, Jean-Jacques…
Sujet: Emergency Management
Type d'élément: Publication
Date de la dernière mise à jour: 2020-04-02
Description: Conducting trials of novel interventions during infectious disease emergencies, such as the ongoing Covid-19 pandemic, is increasingly recognized as important for determining the efficacy of potential vaccines and therapies. -
Créateur: Vasa, A., M. Schwedhelm and D. Johnson
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2015-11-26
Description: Care for patients with Ebola Virus Disease (EVD) and other highly infectious diseases is demanding and requires an unwavering commitment to teamwork and stringent infection control measures. -
Créateur: Fintzi J, Bonnett T, Sweeney DA, Huprikar NA, Ganesan A, Frank MG, McLellan SLF, Dodd LE, Tebas P, Mehta AK.
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-08-19
Description: The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) found that remdesivir therapy hastened recovery in patients hospitalized with COVID-19, but the pathway for this improvement was not explored. We investigated how the dynamics of clinical progression…Conservation strategies: This resource contains recommendations facilitating conservation of equipment and supplies during contingency (expected shortages) and crisis (known shortages) capacities and should not be applied as guidance when conventional capacities are available.
-
Créateur: The RECOVERY Collaborative Group.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-25
Description: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. -
Créateur: The RECOVERY Collaborative Group.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-07-17
Description: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. -
Créateur: the Fundación INFANT–COVID-19 Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-18
Description: Therapies to interrupt the progression of early coronavirus disease 2019 (Covid-19) remain elusive. Among them, convalescent plasma administered to hospitalized patients has been unsuccessful, perhaps because antibodies should be administered earlier… -
Créateur: Fallah MP, Skrip LA.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-01-24
Description: This article reviews the testing of Ebola therapies during the outbreak. -
Créateur: M. Aletti, H. Savini, C. Ficko, J. Bordes, A. Cambon, M. Billhot, G. Velut, et al.
Sujet: Contenu Français
Type d'élément: Publication
Date de la dernière mise à jour: 2017-03-01
Description: La présentation de la maladie à virus Ebola est protéiforme. Le spectre clinique va de formes gravissimes avec défaillances polyviscérales et décès en quelques jours à des formes paucisymptomatiques voire peut-être même asymptomatiques. -
Créateur: WHO
Sujet: Treatment & Care
Type d'élément: Cours en ligne
Date de la dernière mise à jour: 2018-07-05
Description: This comprehensive intermediate level course is for clinicians caring for patients with suspected or confirmed Ebola virus disease (EVD). Modules provide information on screening and triage, infection prevention and control, laboratory diagnostics,…